Targeting Tumor Necrosis Factor—A Therapeutic Strategy for AD

• 2 Comments

29 May 2008

such as Alzheimer's. Yet it is unclear how best to exploit this target to develop a safe and

Pin1, Tau and the Cell Cycle in Alzheimer Disease

03 Aug 1999

proteins, in normal and Alzheimer states; and Pin1 and the paradigm of phosphorylation-dependent prolyl

Will Probing Flies and Worms Bear Fruit in the Search for New Genes Involved in Alzheimer's?

29 Oct 2002

Harvard Medical School and we model neurodegenerative diseases, including Alzheimer's disease and

BDNF and Alzheimer's Disease—What's the Connection?

25 Nov 2003

Cotman and Nicole Berchtold, University of California, Irvine; Gabrielle Strobel, Alzheimer Research

Webinar: Pathogenic Protein Spread? Let’s Think Again

• 3 Comments

28 Mar 2016

proteins as they go. In this manner, a growing number of scientists argue, Alzheimer’s, Parkinson’s, and

From Epidemiology to Therapeutic Trials with Anti-inflammatory Drugs in Alzheimer's Disease: The Role of NSAIDs and Cyclooxygenase on Beta-amyloidosis and Clinical Dementia

• 4 Comments

20 Mar 2002

and the majority of neurons in the most affected areas are probably gone by the time someone has even

Protofibrillar Aβ in Alzheimer's Disease

17 Feb 2000

Dennis Selkoe, Dean Hartley, and William Klein led this live discussion on 17 February 2000.

ADCS Prevention Instrument Project

05 Mar 2007

promise to be long and potentially costly affairs. In a supplement in the October-December 2006 Alzheimer

Insulin Resistance: A Common Axis Linking Alzheimer's, Depression and Metabolism?

06 Jul 2005

would be clinically relevant? We could look with different severities and time durations as well as

Protein Folding and Neurodegeneration: Biophysics to the Rescue?

30 Apr 2003

antigen was about 95 percent pure and you immunized with it 10 times? I find it astounding and fascinating

International Student Workshop on AD

08 Nov 2012

What makes a good grant proposal in Alzheimer’s research? How to develop and present it? What are

Suzanne Hendrix on Constructing Composites for Trials in Early Alzheimer’s

• 1 Comment

25 Nov 2015

successful therapy development in early Alzheimer’s. Senior clinicians in the United States and Europe

Clearing the Fog Around Aβ Oligomers

• 1 Comment

14 Oct 2011

to Alzheimer’s disease. Researchers studying tau and α-synuclein may confront similar challenges

Finding NIH Support for Drug Discovery and Development for Neurodegenerative Diseases

• 2 Comments

09 Apr 2007

Searching for the wherewithal to push on with your work on a promising new Alzheimer therapy? The

The Role of Insulin Resistance in Brain Aging and Dementia

• 2 Comments

06 Nov 2009

suggest that early identification and treatment of insulin resistance may delay or prevent Alzheimer